China Shineway Pharmaceutical Group Limited China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited

2877

Classement en actions #10994
As an investment holding enterprise, China Shineway Pharmaceutical Group... As an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.
Prix de l'action
$0.948573
Capitalisation boursière
$716.55M
Changement (1 jour)
-0.74%
Changement (1 an)
-95.07%
Pays
CN
Échange China Shineway Pharmaceutical Group Limited (2877)

Catégorie

Healthcare
Ratio P/B pour China Shineway Pharmaceutical Group Limited (2877)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de China Shineway Pharmaceutical Group Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour China Shineway Pharmaceutical Group Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes